Maravai Lifesciences Holdings (MRVI) Acquisitions (2022 - 2025)

Maravai Lifesciences Holdings' Acquisitions history runs 3 years deep, the most recent figure standing at $362000.0 for Q2 2025.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $362000.0 in Q2 2025; TTM through Mar 2026 was $362000.0, a 98.06% decrease from a year earlier, with the FY2025 full-year figure at $19.0 million, changed N/A from the prior year.
• Acquisitions slipped to $362000.0 in Q2 2025 per MRVI's latest filing, from $18.6 million in the prior quarter.
• Across five years, Acquisitions topped out at $238.8 million in Q1 2022 and bottomed at -$109000.0 in Q2 2023.
• The 3-year median for Acquisitions is $9.5 million (2025), against an average of $54.6 million.
• Biggest YoY gain for Acquisitions was 70.8% in 2023; the steepest drop was 70.8% in 2023.
• Year by year, Acquisitions stood at $133000.0 in 2022, then tumbled by 181.95% to -$109000.0 in 2023, then jumped by 432.11% to $362000.0 in 2025.
• Per Business Quant, the three latest MRVI Acquisitions figures stand at $362000.0 (Q2 2025), $18.6 million (Q1 2025), and -$109000.0 (Q2 2023).